BRISTOL-MYERS SQUIBB CEPHALOSPORIN CEFIPIME HAS 84% SUCCESS RATE; STREPTOGRAMINS MAY BE ACTIVE AGAINST METHICILLIN-RESISTANT STAPH BACTERIA -- BMNS SYMPOSIUM

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".